Cargando…

Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET

Alzheimer’s disease (AD) is a leading cause of dementia worldwide, associated with cognitive deficits and brain glucose metabolic alteration. However, the associations of glucose metabolic changes with cognitive dysfunction are less detailed. Here, we examined the brains of APP/presenilin 1 (PS1) tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xue-Yuan, Men, Wei-Wei, Zhu, Hua, Lei, Jian-Feng, Zuo, Fu-Xing, Wang, Zhan-Jing, Zhu, Zhao-Hui, Bao, Xin-Jie, Wang, Ren-Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085739/
https://www.ncbi.nlm.nih.gov/pubmed/27763550
http://dx.doi.org/10.3390/ijms17101707
_version_ 1782463634082889728
author Li, Xue-Yuan
Men, Wei-Wei
Zhu, Hua
Lei, Jian-Feng
Zuo, Fu-Xing
Wang, Zhan-Jing
Zhu, Zhao-Hui
Bao, Xin-Jie
Wang, Ren-Zhi
author_facet Li, Xue-Yuan
Men, Wei-Wei
Zhu, Hua
Lei, Jian-Feng
Zuo, Fu-Xing
Wang, Zhan-Jing
Zhu, Zhao-Hui
Bao, Xin-Jie
Wang, Ren-Zhi
author_sort Li, Xue-Yuan
collection PubMed
description Alzheimer’s disease (AD) is a leading cause of dementia worldwide, associated with cognitive deficits and brain glucose metabolic alteration. However, the associations of glucose metabolic changes with cognitive dysfunction are less detailed. Here, we examined the brains of APP/presenilin 1 (PS1) transgenic (Tg) mice aged 2, 3.5, 5 and 8 months using (18)F-labed fluorodeoxyglucose ((18)F-FDG) microPET to assess age- and brain region-specific changes of glucose metabolism. FDG uptake was calculated as a relative standardized uptake value (SUVr). Morris water maze (MWM) was used to evaluate learning and memory dysfunction. We showed a glucose utilization increase in multiple brain regions of Tg mice at 2 and 3.5 months but not at 5 and 8 months. Comparisons of SUVrs within brains showed higher glucose utilization than controls in the entorhinal cortex, hippocampus, and frontal cortex of Tg mice at 2 and 3.5 months but in the thalamus and striatum at 3.5, 5 and 8 months. By comparing SUVrs in the entorhinal cortex and hippocampus, Tg mice were distinguished from controls at 2 and 3.5 months. In MWM, Tg mice aged 2 months shared a similar performance to the controls (prodromal-AD). By contrast, Tg mice failed training tests at 3.5 months but failed all MWM tests at 5 and 8 months, suggestive of partial or complete cognitive deficits (symptomatic-AD). Correlation analyses showed that hippocampal SUVrs were significantly correlated with MWM parameters in the symptomatic-AD stage. These data suggest that glucose metabolic disorder occurs before onset of AD signs in APP/PS1 mice with the entorhinal cortex and hippocampus affected first, and that regional FDG uptake increase can be an early biomarker for AD. Furthermore, hippocampal FDG uptake is a possible indicator for progression of Alzheimer’s cognition after cognitive decline, at least in animals.
format Online
Article
Text
id pubmed-5085739
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-50857392016-11-01 Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET Li, Xue-Yuan Men, Wei-Wei Zhu, Hua Lei, Jian-Feng Zuo, Fu-Xing Wang, Zhan-Jing Zhu, Zhao-Hui Bao, Xin-Jie Wang, Ren-Zhi Int J Mol Sci Article Alzheimer’s disease (AD) is a leading cause of dementia worldwide, associated with cognitive deficits and brain glucose metabolic alteration. However, the associations of glucose metabolic changes with cognitive dysfunction are less detailed. Here, we examined the brains of APP/presenilin 1 (PS1) transgenic (Tg) mice aged 2, 3.5, 5 and 8 months using (18)F-labed fluorodeoxyglucose ((18)F-FDG) microPET to assess age- and brain region-specific changes of glucose metabolism. FDG uptake was calculated as a relative standardized uptake value (SUVr). Morris water maze (MWM) was used to evaluate learning and memory dysfunction. We showed a glucose utilization increase in multiple brain regions of Tg mice at 2 and 3.5 months but not at 5 and 8 months. Comparisons of SUVrs within brains showed higher glucose utilization than controls in the entorhinal cortex, hippocampus, and frontal cortex of Tg mice at 2 and 3.5 months but in the thalamus and striatum at 3.5, 5 and 8 months. By comparing SUVrs in the entorhinal cortex and hippocampus, Tg mice were distinguished from controls at 2 and 3.5 months. In MWM, Tg mice aged 2 months shared a similar performance to the controls (prodromal-AD). By contrast, Tg mice failed training tests at 3.5 months but failed all MWM tests at 5 and 8 months, suggestive of partial or complete cognitive deficits (symptomatic-AD). Correlation analyses showed that hippocampal SUVrs were significantly correlated with MWM parameters in the symptomatic-AD stage. These data suggest that glucose metabolic disorder occurs before onset of AD signs in APP/PS1 mice with the entorhinal cortex and hippocampus affected first, and that regional FDG uptake increase can be an early biomarker for AD. Furthermore, hippocampal FDG uptake is a possible indicator for progression of Alzheimer’s cognition after cognitive decline, at least in animals. MDPI 2016-10-18 /pmc/articles/PMC5085739/ /pubmed/27763550 http://dx.doi.org/10.3390/ijms17101707 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Xue-Yuan
Men, Wei-Wei
Zhu, Hua
Lei, Jian-Feng
Zuo, Fu-Xing
Wang, Zhan-Jing
Zhu, Zhao-Hui
Bao, Xin-Jie
Wang, Ren-Zhi
Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET
title Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET
title_full Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET
title_fullStr Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET
title_full_unstemmed Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET
title_short Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using (18)F-FDG-PET
title_sort age- and brain region-specific changes of glucose metabolic disorder, learning, and memory dysfunction in early alzheimer’s disease assessed in app/ps1 transgenic mice using (18)f-fdg-pet
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085739/
https://www.ncbi.nlm.nih.gov/pubmed/27763550
http://dx.doi.org/10.3390/ijms17101707
work_keys_str_mv AT lixueyuan ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT menweiwei ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT zhuhua ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT leijianfeng ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT zuofuxing ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT wangzhanjing ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT zhuzhaohui ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT baoxinjie ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet
AT wangrenzhi ageandbrainregionspecificchangesofglucosemetabolicdisorderlearningandmemorydysfunctioninearlyalzheimersdiseaseassessedinappps1transgenicmiceusing18ffdgpet